Dr. Ken Rabin, based in Warsaw, Poland, has more than 50 years of experience in public affairs, marketing communications, and education, primarily in healthcare. He currently serves as a special projects editor of the Journal of Health Communication and as a senior counselor to Alfa Communications in Warsaw. Rabin also holds a position at the CUNY School of Public Health.
Since 2019, Rabin has collaborated with Dr. Scott Ratzan, Prof. Jeffrey Lazarus, and other experts on international and U.S. academic studies and editorials concerning vaccine hesitancy, COVID-19 communications, and immunization issues. His past clients include Johnson & Johnson—where he contributed to the Campaign for Nursing’s Future—Sanofi, Merck, L’Oréal, UNESCO, PhRMA, and IFPMA. His campaigns have won a Silver Anvil, a Gold Quill, and the Big Apple Award from the New York PRSA.
Rabin has held executive roles at Ruder Finn, Burson-Marsteller, and Hill & Knowlton, including executive vice president of international healthcare, managing director of the worldwide healthcare practice, and chairman of InterScience, a global healthcare PR company later acquired by 3BCom/Medicus. He also served as director of public affairs at Squibb (now Bristol Myers Squibb). Before entering the corporate sector, Rabin was an associate professor and director of the graduate public relations program at American University in Washington, D.C., a communications specialist at Meharry Medical College, and a U.S. Information Agency foreign service officer in Africa.
Rabin holds a Bachelor of Arts degree from Cornell University, a Master of Arts degrees from Yale University and the University of North Carolina, and a Ph.D. in higher education administration from George Peabody College of Vanderbilt University.